Junyi Li

1.2k total citations · 2 hit papers
32 papers, 837 citations indexed

About

Junyi Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Junyi Li has authored 32 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 10 papers in Immunology. Recurrent topics in Junyi Li's work include Drug Transport and Resistance Mechanisms (4 papers), Inflammatory Bowel Disease (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Junyi Li is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Inflammatory Bowel Disease (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Junyi Li collaborates with scholars based in China, Hong Kong and Russia. Junyi Li's co-authors include Haifeng Zhou, Fei Sun, Allan R. Brasier, Heng Fan, Desheng Hu, Faxi Wang, Jia Yang, Ge Zhang, Alexey Sarapultsev and Yalan Dong and has published in prestigious journals such as Scientific Reports, Kidney International and Hypertension.

In The Last Decade

Junyi Li

31 papers receiving 822 citations

Hit Papers

Berberine ameliorates DSS-induced intestinal mucosal barr... 2022 2026 2023 2024 2022 2023 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway
    2022 116 citations Yalan Dong, Heng Fan et al. International Journal of Biological Sciences profile →
  2. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation
    2023 113 citations Ting Yu, Junjie Lu et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyi Li China 17 384 131 111 111 110 32 837
Rina Kato Japan 20 357 0.9× 267 2.0× 86 0.8× 79 0.7× 90 0.8× 52 1.1k
Jiahui Li China 20 363 0.9× 133 1.0× 102 0.9× 179 1.6× 72 0.7× 55 976
Fang Zhong China 19 417 1.1× 100 0.8× 58 0.5× 70 0.6× 74 0.7× 47 900
Qianwen Wang China 18 465 1.2× 135 1.0× 129 1.2× 151 1.4× 50 0.5× 63 1.0k
N. Yoshida Japan 20 322 0.8× 250 1.9× 119 1.1× 93 0.8× 101 0.9× 65 1.4k
Zhonghong Wei China 17 449 1.2× 114 0.9× 120 1.1× 83 0.7× 49 0.4× 37 903
Yu‐Chi Chen China 19 465 1.2× 297 2.3× 115 1.0× 114 1.0× 107 1.0× 66 1.1k
Chen Xie China 16 330 0.9× 171 1.3× 163 1.5× 41 0.4× 60 0.5× 32 842

Countries citing papers authored by Junyi Li

Since Specialization
Citations

This map shows the geographic impact of Junyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyi Li more than expected).

Fields of papers citing papers by Junyi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyi Li. The network helps show where Junyi Li may publish in the future.

Co-authorship network of co-authors of Junyi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junyi Li. A scholar is included among the top collaborators of Junyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyi Li. Junyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouyang, Xiaohu, Lan Lin, Junyi Li, et al.. (2024). Luteolin protects against myocardial ischemia/reperfusion injury by reducing oxidative stress and apoptosis through the p53 pathway. Journal of Integrative Medicine. 22(6). 652–664.
2.
Ma, Qingfeng, Jie Li, Xue Wang, et al.. (2024). HBV promotes its replication by up-regulating RAD51C gene expression. Scientific Reports. 14(1). 2607–2607. 1 indexed citations
3.
Chen, Wenfang, Jean de Dieu Habimana, Yirong Sun, et al.. (2024). NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route. Cancer Cell International. 24(1). 64–64. 2 indexed citations
4.
Li, Junyi, Shaoqing Yang, Dan Liu, et al.. (2024). Neoagarotetraose Alleviates Atherosclerosis via Modulating Cholesterol and Bile Acid Metabolism in ApoE−/− Mice. Nutrients. 16(10). 1502–1502. 5 indexed citations
5.
Chen, Qianyun, Xunxun Wang, Xiaohu Ouyang, et al.. (2024). The combination of Tanshinone IIA and Astragaloside IV attenuates myocardial ischemia–reperfusion injury by inhibiting the STING pathway. Chinese Medicine. 19(1). 16 indexed citations
6.
Wang, Jingbo, Shuxin Song, Junyi Li, et al.. (2024). Sophora alopecuroide - Taraxacum decoction (STD) inhibits non-small cell lung cancer via inducing ferroptosis and modulating tumor immune microenvironment. Heliyon. 10(20). e39564–e39564. 4 indexed citations
7.
Zhou, Haifeng, Junyi Li, Yun Huang, et al.. (2023). Quercetin serves as the major component of Xiang-lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1/PPARγ and dictating the alternative activation of macrophage. Journal of Ethnopharmacology. 313. 116557–116557. 29 indexed citations
8.
Yu, Ting, Junjie Lu, Xiaohu Ouyang, et al.. (2023). Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. International Journal of Biological Sciences. 19(5). 1471–1489. 113 indexed citations breakdown →
9.
10.
Li, Mingyue, Weina Guo, Yalan Dong, et al.. (2022). Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice. Genomics Proteomics & Bioinformatics. 20(2). 288–303. 37 indexed citations
11.
Li, Junyi, Yanchao Guo, Haifeng Zhou, et al.. (2022). Arginine metabolism regulates the pathogenesis of inflammatory bowel disease. Nutrition Reviews. 81(5). 578–586. 49 indexed citations
12.
Li, Junyi, Jun Xiao, Min Gao, et al.. (2021). IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. International Immunopharmacology. 92. 107350–107350. 18 indexed citations
13.
Yu, Ting, Xingxing Liu, Junyi Li, et al.. (2021). Extracellular vesicles derived from EphB2-overexpressing bone marrow mesenchymal stem cells ameliorate DSS-induced colitis by modulating immune balance. Stem Cell Research & Therapy. 12(1). 181–181. 25 indexed citations
14.
Li, Junyi, Haifeng Zhou, Xiaoxia Fu, et al.. (2021). Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease. Immunology Letters. 232. 39–44. 25 indexed citations
15.
Zhou, Haifeng, Junyi Li, Fei Sun, et al.. (2020). A Review on Recent Advances in Aloperine Research: Pharmacological Activities and Underlying Biological Mechanisms. Frontiers in Pharmacology. 11. 538137–538137. 31 indexed citations
16.
Liu, Chunyun, Junyi Li, Yingrong Du, et al.. (2020). Analysis of pathological changes and related factors in liver tissue of HBeAg-negative patients with low HBsAg levels. Clinical and Experimental Medicine. 20(4). 577–586. 1 indexed citations
17.
Li, Junyi, Fei Sun, Haifeng Zhou, et al.. (2019). A Systematic Review Exploring the Anticancer Activity and Mechanisms of Glucomannan. Frontiers in Pharmacology. 10. 930–930. 24 indexed citations
18.
Huang, Yuqin, Quan Zhou, Wenguo Wang, et al.. (2019). Acinetobacter baumannii Ventilator-Associated Pneumonia: Clinical Efficacy of Combined Antimicrobial Therapy and in vitro Drug Sensitivity Test Results. Frontiers in Pharmacology. 10. 92–92. 32 indexed citations
19.
Li, Junyi, Fei Sun, Yanchao Guo, & Heng Fan. (2018). High-Salt Diet Gets Involved in Gastrointestinal Diseases through the Reshaping of Gastroenterological Milieu. Digestion. 99(4). 267–274. 28 indexed citations
20.
Brasier, Allan R., et al.. (1994). Transcription factors modulating angiotensinogen gene expression in hepatocytes. Kidney International. 46(6). 1564–1566. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rina Kato Breakdown of academic impact, for papers by Jiahui Li Breakdown of academic impact, for papers by Fang Zhong Breakdown of academic impact, for papers by Qianwen Wang Breakdown of academic impact, for papers by N. Yoshida Breakdown of academic impact, for papers by Zhonghong Wei Breakdown of academic impact, for papers by Yu‐Chi Chen Breakdown of academic impact, for papers by Chen Xie
Rankless by CCL
2026